Vitiligo Medical Treatment Advances | Expert Insights
vitiligoNext Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Amit Pandya, staff dermatologist with Palo Alto Foundation Medical Group and adjunct professor in the department of dermatology at the University of Texas Southwestern Medical Center. Dr. Pandya says this is the most exciting time for him as a dermatologist with new vitiligo medications on the market an …
vitiligo
Benefits and Risks of Medium & Deep Chemical Peels
chemical peelsNext Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium (PDE) interviewed Dr. Jennifer Rullan, a dermatologist in Chula Vista, Calif. Watch as Dr. Rullan outlines unexpected ingredients that dermatologists can use in medium depth and deep chemical peels to treat pigmentary disorders, and it may not be the disorders that you expect. Vitiligo? Idiopathic guttate hypomelanosis …
chemical peels
Patient Buzz: Rare Pediatric Skin Conditions | The Expert Weighs In
pediatric skin conditionsParade and other media outlets recently covered the story of actress Mandy Moore's son, who was diagnosed with Gianotti-Crosti syndrome. What should dermatology clinicians know about Gianotti-Crosti syndrome and other rare pediatric skin conditions? What should dermatology clinicians do when they are unsure of how to diagnose a pediatric skin condition?  For expert advice, I reached out to …
pediatric skin conditions
Medicolegal Implications of Regenerative Medicine and PRP
PRPNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Terrance Keaney, assistant clinical faculty of dermatology at GW School of Medicine and Health Sciences, and Howard University. Watch and find out why the FDA and Department of Justice are giving more attention to regenerative medicine in recent years. Learn how the FDA views platelet-ri …
PRP
What You Should Know About Ingredients in FDA-Approved Neuromodulators
neuromodulatorsNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Terrance Keaney, assistant clinical faculty of dermatology at GW School of Medicine and Health Sciences, and Howard University. Dr. Keaney says there’s more to neuromodulators than the active protein -- other proteins in the vials could play a role in treatment effectiveness. Could eve …
neuromodulators
error

Enjoy this blog? Please spread the word :)